Intermittent letrozole as adjuvant treatment in postmenopausal hormone-receptor positive early breast cancer patients

被引：0
|
作者：
Balduzzi, A.
Bagnardi, V.
Volpe, S.
Cancello, G.
Iorfida, M.
Dellapasqua, S.
Sandri, M.
Goldhirsch, A.
Colleoni, M.
机构：
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/0008-5472.SABCS13-P1-13-12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-13-12
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Effect of concomitant statin treatment in postmenopausal patients with hormone-receptor positive early-stage breast cancer receiving adjuvant denosumab or placebo: A post-hoc analysis of ABCSG-18
    Minichsdorfer, Christoph
    Fuereder, Thorsten
    Leutner, Michael
    Singer, Christian F.
    Kacerovsky-Strobl, Stephanie
    Egle, Daniel
    Greil, Richard
    Balic, Marija
    Fitzal, Florian
    Pfeiler, Georg
    Frantal, Sophie
    Bartsch, Rupert A.
    Gnant, Michael
    CANCER RESEARCH, 2022, 82 (04)
  • [32] Comparative efficacy study of 5-year letrozole or anastrozole in postmenopausal hormone receptor-positive early breast cancer
    Sendur, M. A. N.
    Aksoy, S.
    Zengin, N.
    Altundag, K.
    JOURNAL OF BUON, 2013, 18 (04): : 838 - 844
  • [33] Endocrine Effects of Adjuvant Letrozole Compared With Tamoxifen in Hormone-Responsive Postmenopausal Patients With Early Breast Cancer: The HOBOE Trial
    Rossi, Emanuela
    Morabito, Alessandro
    Di Rella, Francesca
    Esposito, Giuseppe
    Gravina, Adriano
    Labonia, Vincenzo
    Landi, Gabriella
    Nuzzo, Francesco
    Pacilio, Carmen
    De Maio, Ermelinda
    Di Maio, Massimo
    Piccirillo, Maria Carmela
    De Feo, Gianfranco
    D'Aiuto, Giuseppe
    Botti, Gerardo
    Chiodini, Paolo
    Gallo, Ciro
    Perrone, Francesco
    de Matteis, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) : 3192 - 3197
  • [34] Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study
    Fasching, P. A.
    Fehm, T.
    Kellner, S.
    de Waal, J.
    Rezal, M.
    Baler, B.
    Baake, G.
    Kolberg, H. -C
    Guggenberger, M.
    Warm, N.
    Harbeck, N.
    Wuerstlein, R.
    Deuker, J. -U
    Dall, P.
    Richter, B.
    Wachsmann, G.
    Brucker, C.
    Siebers, J. W.
    Fersis, N.
    Kuhn, T.
    Wolf, C.
    Vollert, H. -W
    Breitbach, G. -P
    Janni, W.
    Landthaler, R.
    Kohls, A.
    Rezek, D.
    Nosslet, T.
    Fischer, G.
    Henschen, S.
    Praetz, T.
    Heyl, V.
    Kuehn, T.
    Krauss, T.
    Thomssen, C.
    Kuemmel, S.
    Hohn, A.
    Tesch, H.
    Mundhenke, C.
    Hein, A.
    Rauh, C.
    Bayer, C. M.
    Jacob, A.
    Schmidt, K.
    Belleville, E.
    Hadji, P.
    Wallwiener, D.
    Grischice, E. -M
    Beckmann, M. W.
    Brucker, S. Y.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2014, 74 (12) : 1137 - 1143
  • [35] Phase I trial of the combination of the multikinase inhibitor nintedanib plus letrozole: A window of opportunity trial in adjuvant hormone-receptor positive breast cancer (HRPBC).
    Rodriguez, Laura Medina
    Guerra, Juan Antonio
    Malon, Diego
    Laura, Rodriguez
    Colomer, Ramon
    Quintela-Fandino, Miguel
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [36] Vitamin D supplementation and response to aromatase inhibitors in postmenopausal women with hormone-receptor positive breast cancer
    Dizdar, Omer
    Bulut, Nilufer
    Altundag, Kadri
    BREAST, 2008, 17 (02): : 120 - 120
  • [37] New approaches for hormone-receptor positive metastatic breast cancer
    Thanopoulou E.
    Johnston S.R.D.
    Current Breast Cancer Reports, 2013, 5 (4) : 309 - 320
  • [38] DOES ADJUVANT CHEMOTHERAPY BENEFIT PATIENTS WITH NODE-POSITIVE, HORMONE-RECEPTOR POSITIVE, AND HER2 NEGATIVE BREAST CANCER?
    Harano, K.
    Hashimoto, K.
    Shimizu, C.
    Hirata, T.
    Yonemori, K.
    Tamura, K.
    Katsumata, N.
    Ando, M.
    Fujiwara, Y.
    ANNALS OF ONCOLOGY, 2010, 21 : 90 - 91
  • [39] Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer in Korea
    Beom, Seung Hoon
    Oh, Jisu
    Kim, Tae-Yong
    Lee, Kyung-Hun
    Yang, Yaewon
    Suh, Koung Jin
    Moon, Hyeong-Gon
    Han, Sae-Won
    Oh, Do-Youn
    Han, Wonshik
    Kim, Tae-You
    Noh, Dong-Young
    Im, Seock-Ah
    CANCER RESEARCH AND TREATMENT, 2017, 49 (02): : 454 - 463
  • [40] Impact of early dose reduction of palbociclib on clinical outcomes in patients with hormone-receptor positive metastatic breast cancer
    Moftakhar, Bahar
    Lekkala, Manidhar Reddy
    Strawderman, Myla
    Smith, Tae C.
    Meacham, Philip
    Fitzgerald, Bryan
    Dhakal, Ajay
    CANCER RESEARCH, 2020, 80 (04)
12345